Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alta Equipment (ALTG) Asset Writedowns and Impairment (2019 - 2025)

Alta Equipment (ALTG) has 7 years of Asset Writedowns and Impairment data on record, last reported at $300000.0 in Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment fell 40.0% year-over-year to $300000.0; the TTM value through Dec 2025 reached $3.2 million, down 43.86%, while the annual FY2025 figure was $3.2 million, 43.86% down from the prior year.
  • Asset Writedowns and Impairment reached $300000.0 in Q4 2025 per ALTG's latest filing, down from $400000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $2.1 million in Q4 2023 and bottomed at $300000.0 in Q4 2025.
  • Average Asset Writedowns and Impairment over 5 years is $1.3 million, with a median of $1.3 million recorded in 2022.
  • Peak YoY movement for Asset Writedowns and Impairment: soared 110.0% in 2023, then crashed 76.47% in 2025.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $800000.0 in 2021, then grew by 25.0% to $1.0 million in 2022, then skyrocketed by 110.0% to $2.1 million in 2023, then crashed by 76.19% to $500000.0 in 2024, then plummeted by 40.0% to $300000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were $300000.0 in Q4 2025, $400000.0 in Q3 2025, and $900000.0 in Q2 2025.